DrugPatentWatch Database Preview
Drugs in Development Information for motexafin gadolinium
» See Plans and Pricing
What is the development status for investigational drug motexafin gadolinium?
motexafin gadolinium is an investigational drug.
There have been 36 clinical trials for motexafin gadolinium.
The most recent clinical trial was a Phase 3 trial.
The most common disease conditions in clinical trials are Lung Neoplasms, Lymphoma, and Nervous System Neoplasms. The leading clinical trial sponsors are Pharmacyclics LLC., National Cancer Institute (NCI), and Northwestern University.
Summary for motexafin gadolinium
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3 |
| WIPO Patent Applications | 1,420 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (1969-12-31) |
| Vendors | 11 |
Recent Clinical Trials for motexafin gadolinium
| Title | Sponsor | Phase |
|---|---|---|
| Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma | Spectrum Pharmaceuticals, Inc | Phase 2 |
| Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy | National Cancer Institute (NCI) | N/A |
| Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy | American College of Radiology Imaging Network | N/A |
Clinical Trial Summary for motexafin gadolinium
Top disease conditions for motexafin gadolinium
Top clinical trial sponsors for motexafin gadolinium
US Patents for motexafin gadolinium
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
